Guangzhou Boji Medical Biotechnological Co., Ltd (Boji for short) was founded in 1998 andrestructured in 2002. The current registered capital is more than 10 million dollars. Boji is the earliest registered and the most experiential CRO in China. Boji is a high-tech enterprise that provides full services including regulatory affairs, preclinical research, clinical trials for phase I~IV, PMS, clinical trial for medical devices, data management and biostatistics, SMO etc.
With development for more than 10 years, Boji now has 6 subsidiaries, 25 local offices in China and several overseas offices. Boji occupies the leading position of Chinese CRO industry in its achievements, professional standards, company size and revenue.
Since foundation, Boji has provided thousands of professional services in different R&D processes for more than 500 customers:
1.More than 650 clinical trials (phaseI-V, PMS and medical devices)
2.More than 500 pre-clinical studies (efficacy, PK/PD, toxicology, CMC research)
Boji has helped its clients get:
1.More than 30 clinical trial authorizations (CTA)
2.More than 60 new drug certificates
3.More than 100 drug manufacturing certificates